BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, December 11, 2025
Home
»
Newsletters
» BioWorld
BioWorld
Feb. 12, 2004
View Archived Issues
What Motivates Cancer Patients To Enroll Voluntarily In Clinical Trials? Do They Improve Health Outcomes?
Read More
New BIO Conference Welcomes Small, Mid-Caps In 'H&Q' Style
Read More
Other News To Note
Read More
Appointments And Advancements
Read More
InterMune To Restructure Debt With $150M Notes Placement
InterMune Inc. raised $150 million in a private placement of convertible senior notes as part of a plan to reduce its burn rate and narrow its focus in two therapeutic areas. (BioWorld Today)
Read More
Corcept Tries Again: Company Files For Estimated $80M IPO
Read More
